Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study-Reference-Cited by-同舟云学术

Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study

Published:2020-02-11 Issue:2 Volume:7 Page:559-566
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Revuelta‐López Elena¹²,Núñez Julio²³,Gastelurrutia Paloma¹²,Cediel Germán⁴,Januzzi James L.⁵,Ibrahim Nasrien E.⁵,Emdin Michele⁶,VanKimmenade Roland⁷,Pascual‐Figal Domingo²⁸,Núñez Eduardo³,Gommans Frank⁷,Lupón Josep²⁴⁹,Bayés‐Genís Antoni²⁴⁹

Affiliation:

1. Heart Failure and Cardiac Regeneration (ICREC) Research Program Health Science Research Institute Germans Trias i Pujol (IGTP) Badalona Spain

2. Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares, (CIBERCV,) Madrid Spain

3. Cardiology Department Hospital Clínico Universitario, Universitat de València, INCLIVA Valencia, Spain; INCLIVA; Universitat de València Valencia Spain

4. Cardiology Service and Heart Failure Unit Hospital Universitari Germans Trias i Pujol Badalona Spain

5. Division of Cardiology Massachusetts General Hospital and Cardiometabolic Trials, Baim Institute for Clinical Research Boston Massachusetts, MA USA

6. Institute of Life Sciences Scuola Superiore Sant'Anna, Fondazione Toscana Gabriele Monasterio Pisa, Italy; Fondazione Toscana Gabriele Monasterio Pisa Italy

7. Department of Cardiology Radboud University Medical Centre Nijmegen The Netherlands

8. Cardiology Department, Hospital Virgen de la Arrixaca Universidad de Murcia Murcia Spain

9. Department of Medicine Autonomous University of Barcelona Barcelona Spain

Funder

Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares

Fundació la Marató de TV3

Instituto de Salud Carlos III

Agència de Gestió d'Ajuts Universitaris i de Recerca

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12607

Reference35 articles.

1. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

2. Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

3. Combined Neprilysin and Renin-Angiotensin System Inhibition for the Treatment of Heart Failure

4. Estrategia multimarcador para estratificar el pronóstico en insuficiencia cardiaca. Valor de los marcadores neurohumorales: neprilisina frente a NT-proBNP

5. Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective;Journal of Cellular and Molecular Medicine;2023-10-17

2. Possible role of LCZ696 in atherosclerosis: new inroads and perspective;Molecular and Cellular Biochemistry;2023-08-01

3. Effects of neprilysin and neprilysin inhibitors on glucose homeostasis: Controversial points and a promising arena;Journal of Diabetes;2023-04-19

4. Neprilysin 4: an essential peptidase with multifaceted physiological relevance;Biological Chemistry;2023-01-19

5. Finding a reliable assay for soluble neprilysin;Clinical Biochemistry;2022-06